Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05144685 · ClinicalTrials.gov registry record · Phase 2
A Study to Evaluate the Safety and Effectiveness of a Digital Therapeutic
A Phase 2 study, sponsored by Oui Therapeutics.
- Terminated
- Registry status
- Phase 2
- Development phase
- 356
- Enrollment target
NCT05144685 is a Phase 2 study that was terminated before completion, run by Oui Therapeutics. The registered enrollment target is 356 participants.
The verdict
NCT05144685, a Phase 2 study, was terminated before completion, sponsored by Oui Therapeutics.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 356 participants
- Enrollment target
Study Summary
The primary objective of this study is to assess the effectiveness of a digital intervention in reducing suicide attempts.
Interventions
- BEHAVIORAL Treatment as Usual
- DEVICE OTX-202
- DEVICE OTX-000
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 356 participants |
| Start Date | 2022-04-07 |
| Est. Completion | 2024-06-14 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05144685
The ClinicalTrials.gov registry entry for NCT05144685 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 356 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oui Therapeutics, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Treatment as Usual is the first listed.
NCT05144685 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05144685 about?
NCT05144685 is a clinical study titled "A Study to Evaluate the Safety and Effectiveness of a Digital Therapeutic". The primary objective of this study is to assess the effectiveness of a digital intervention in reducing suicide attempts.
What is the current status of trial NCT05144685?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 356 participants. The study started on 2022-04-07. Estimated completion is 2024-06-14.
What interventions are being tested in trial NCT05144685?
The interventions under investigation include: Treatment as Usual (BEHAVIORAL), OTX-202 (DEVICE), OTX-000 (DEVICE).
Who is sponsoring clinical trial NCT05144685?
This trial is sponsored by Oui Therapeutics, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.